title: Treatment of hypertension in a managed care setting.
abstract: BACKGROUND
  Based on recommendations of the Fifth and Sixth Reports of the Joint National Committee (JNC) on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, Health Care Plan (now Univera Healthcare) Buffalo, NY, developed a clinical guideline to improve the management of patients with hypertension. To increase awareness and utilization, the guideline was distributed as hard copy reports and made available through our electronic information system.
  
  
  OBJECTIVE
  To determine blood pressure (BP) control rates and adherence to guideline recommendations.
  
  
  METHODS
  Retrospective chart review.
  
  
  METHODS
  We randomly sampled hypertensive patients seen during 1998 to evaluate hypertension management. Computerized medical and pharmacy records were reviewed for patient demographics, antihypertensive medications, comorbid conditions, and BP readings. Patient assessment was based on antihypertensive regimen and achievement of target BP according to the recommendations of the guidelines (< 140/90 mm Hg for the general population and < 130/85 mm Hg for special populations). In addition, we assessed control rates using traditional Health Plan Employer Data and Information Set (HEDIS) measures (< 140/90 mm Hg).
  
  
  RESULTS
  Overall, 35% of patients achieved target BP and 68% were treated with agents recommended by our JNC-based guideline. In contrast, using traditional HEDIS measures, 41% of patients achieved BP control. Of 39 patients with compelling indications (primarily diabetic patients), 13% achieved BP target and 67% were treated with recommended agents.
  
  
  CONCLUSIONS
  The impact of our clinical guideline is reflected through the relatively high utilization of recommended drugs. However, optimal BP control continues to be problematic. In particular, patients with diabetes warrant focused attention.
authors.affiliation: School of Pharmacy, University of Buffalo, State University of New York, USA.
authors.forename: L
authors.initials: L
authors.lastname: DiTusa
authors.forename: A B
authors.initials: AB
authors.lastname: Luzier
authors.forename: D E
authors.initials: DE
authors.lastname: Jarosz
authors.forename: B D
authors.initials: BD
authors.lastname: Snyder
authors.forename: J L
authors.initials: JL
authors.lastname: Izzo
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure; D019468:Disease Management; D005260:Female; D019983:Guideline Adherence; D006302:Health Services Research; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008329:Managed Care Programs / Q000458:organization & administration*; D009518:New York
chemical_list: D000959:Antihypertensive Agents